Navigation Links
Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
Date:4/20/2009

aring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. For more information call 1-800-KARMANOS or go to www.karmanos.org.


'/>"/>
SOURCE Karmanos Cancer Institute
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
2. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
3. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
4. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
5. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women
6. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
7. Muscadine Grape Skin Dietary Supplement Protects against Cancer Therapy Radiation Side Effects
8. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
9. New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers
10. Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers
11. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- EuroPharma, Inc. signs exclusive multi-year contract ... super absorbency BCM-95® curcumin and specialized BosPure® ... exclusive distribution territory for these clinically-studied ingredients ... and professional channel, which includes allopathic doctors, ... is a highly absorbable curcumin. Human ...
(Date:12/16/2009)... 16 Verathon®, maker of BladderScan® ... that portable bladder volume ultrasound is now ... for the Prevention of Catheter-Associated Urinary Tract ... introduced in early November 2009, replace the ... The guidelines are located on the ...
(Date:12/16/2009)... Biovista Inc.,today announced that it was awarded the ... 2009 New England Venture Summit, held on December ... edge private companies,driving the future of innovation, was ... privately held companies that play a leading role ... sectors. , "We are ...
Breaking Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5Biovista Inc. Named Top Innovator in Life Sciences 2TOPICA Elects G Kirk Raab as Chairman of the Board 51901 1TOPICA Elects G Kirk Raab as Chairman of the Board 51901 2Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St Louis Mo 51896 1Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St Louis Mo 51896 2Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St Louis Mo 51896 3NeoStem Inc Appoints Leading Chinese Medical Official to Its Advisory Board 13062 1NeoStem Inc Appoints Leading Chinese Medical Official to Its Advisory Board 13062 2NeoStem Inc Appoints Leading Chinese Medical Official to Its Advisory Board 13062 3
... Doctors often mistake the,symptoms of thyroid disease for ... even dementia, says a new edition of a ... diseases are so,wide-ranging, particularly in older men and ... cause and instead focus on common,illnesses that occur ...
... TAIPEI, Taiwan, Aug. 10 /Xinhua-PRNewswire/ -- TaiGen Biotechnology,Inc. ... the,global double-blind Phase II clinical trial of Nemonoxacin ... A total of 265,patients have been admitted to ... expected in the last quarter of 2007. In ...
Other Medicine Technology:You May Have a Thyroid Problem and Not Know It - Particularly If You're Over 60, Says a New Harvard Medical School Report 2TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP) 2
(Date:12/17/2009)... provide Baptist with on-going Healthcare Cost/Risk Analysis reports, activity measures ... improvements as it translates toward reduced claim costs and positive ... , ... Jacksonville, FL (PRWEB) ... risk management company specializing in clinical/claims based cost risk analysis ...
(Date:12/16/2009)... BERKELEY, Calif., Dec. 17 If proposed ... new standards in the employer-based insurance system. Approximately ... the age of 65 rely upon employer-based insurance ... House and Senate versions of reform legislation entail ... vast majority of employees work for firms that ...
(Date:12/16/2009)... Benefit of Children with Autism and Other Special Needs, ... Zachary Levi Join Ben Stiller to Ring in the ... -- At its 13th annual Teddy Bear Ball, The ... & CEO Brian Goldner received the ... far-reaching philanthropic leadership and commitment to children,s causes; ...
(Date:12/16/2009)... -- Immucor, Inc. (Nasdaq: BLUD ), a global ... transfusion industry, today announced that Paul D. Mintz, M.D. ... independent director, effective January 1, 2010. ,, Dr. ... medicine for more than 30 years. He is a ... of Virginia School of Medicine. He also serves as ...
(Date:12/16/2009)... ANN ARBOR, Mich., Dec. 16 The most widely ... a finding that raises social justice questions that must ... benefit from stem cell advances, according to a University ... study of its kind, the U-M team analyzed 47 ... commonly used by stem cell researchers. The scientists determined ...
Breaking Medicine News(10 mins):Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5
... AIMM) today reported a net loss of $8,000, or break ... September 30, 2007, compared,with a net loss of $36,000, or ... ended September 30, 2006. For the nine months ended,September 30, ... share basic,and diluted, compared with net loss of $517,000, or ...
... Aid Rod,Holder has a suspender-like harness that allows ... The Eliminator Racing Chair is recommended for,athletes with ... in and out,of the chair. (Photo: ... the elements or crave competition, Good Shepherd,Rehabilitation Network,s ...
... tissue, VALLEJO, Calif., Nov. 8 Sutter ... the most advanced and accurate,radiation therapy system available. ... North Bay region customized cancer treatment,resulting in quicker, ... breast, prostate, head, neck and lung cancers. ...
... ROANOKE, Va., Nov. 8 This should be a ... to the next can wear on the body,and dampen the ... can provide you with the comfort, support, and,protection your body ... each other and that requires,some travel for them to be ...
... Nov. 8 Top executives of sports ... Bulletin,Board: NNTN) http://www.naturalnutritioninc.com will be ... Vegas, the world,s largest event for healthy ... 6-8, 2007.,Interactive Nutrition,s professionals constantly travel to,ingredient/packaging ...
... products, SEATTLE, Nov. 8 Cell Therapeutics, Inc. ... has been appointed,the company,s Vice President, Commercial Operations. Fong ... marketing experience. Most recently, Fong,was National Sales Director at ... the launch of Ranexa(R) for chronic angina. CTI,recently agreed ...
Other Medicine News:Health News:AutoImmune Inc. Reports 2007 Third Quarter Financial Results 2Health News:AutoImmune Inc. Reports 2007 Third Quarter Financial Results 3Health News:Holiday Gift Giving for Outdoor Enthusiasts With Disabilities and Special Needs 2Health News:Sutter Solano Cancer Center Offers Oncology Patients Customized Cancer Treatment 2Health News:Holiday Travel Causing Stress? 2Health News:Natural Nutrition's Top Executives Attend Supply Side Show West in Las Vegas 2Health News:Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations 2Health News:Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations 3
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: